Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates

被引:9
作者
Liu, Manjuan [1 ]
Mallinger, Aurelie [1 ]
Tortorici, Marcello [1 ]
Newbatt, Yvette [1 ]
Richards, Meirion [1 ]
Mirza, Amin [1 ]
van Montfort, Rob L. M. [1 ]
Burke, Rosemary [1 ]
Blagg, Julian [1 ]
Kaserer, Teresa [1 ]
机构
[1] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England
关键词
DNA CYTOSINE; CATALYTIC DOMAIN; STRUCTURAL BASIS; HUMAN CANCERS; DEAMINATION; MUTAGENESIS; RESTRICTION; MUTATION; BINDING;
D O I
10.1021/acschembio.8b00639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
APOBEC3B (A3B) deamination activity on ssDNA is considered a contributing factor to tumor heterogeneity and drug resistance in a number of human cancers. Despite its clinical impact, little is known about A3B ssDNA substrate preference. We have used nuclear magnetic resonance to monitor the catalytic turnover of A3B substrates in real-time. This study reports preferred nucleotide sequences for A3B substrates, including optimized 4-mer oligonucleotides, and reveals a breadth of substrate recognition that includes DNA sequences known to be mutated in drug-resistant cancer clones. Our results are consistent with available clinical and structural data and may inform the design of substrate-based A3B inhibitors.
引用
收藏
页码:2427 / 2432
页数:6
相关论文
共 50 条
  • [21] Evidence for APOBEC3B mutagenesis in multiple human cancers
    Burns, Michael B.
    Temiz, Nuri A.
    Harris, Reuben S.
    [J]. NATURE GENETICS, 2013, 45 (09) : 977 - +
  • [22] The surprising activities of APOBEC3B and 5-fluorouracil
    Walton, Emma L.
    [J]. BIOMEDICAL JOURNAL, 2015, 38 (02) : 97 - 100
  • [23] Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes
    Sanchez, Ambrocio
    Ortega, Pedro
    Sakhtemani, Ramin
    Manjunath, Lavanya
    Oh, Sunwoo
    Bournique, Elodie
    Becker, Alexandrea
    Kim, Kyumin
    Durfee, Cameron
    Temiz, Nuri Alpay
    Chen, Xiaojiang S.
    Harris, Reuben S.
    Lawrence, Michael S.
    Buisson, Remi
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)
  • [24] APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma
    Kosumi, Keisuke
    Baba, Yoshifumi
    Ishimoto, Takatsugu
    Harada, Kazuto
    Nakamura, Kenichi
    Ohuchi, Mayuko
    Kiyozumi, Yuki
    Izumi, Daisuke
    Tokunaga, Ryuma
    Taki, Katsunobu
    Higashi, Takaaki
    Miyata, Tatsunori
    Shigaki, Hironobu
    Kurashige, Junji
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Yoshida, Naoya
    Oki, Eiji
    Watanabe, Masayuki
    Baba, Hideo
    [J]. MEDICAL ONCOLOGY, 2016, 33 (03) : 1 - 9
  • [25] APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance
    Schmitt, Christina
    Lucius, Ralph
    Synowitz, Michael
    Held-Feindt, Janka
    Hattermann, Kirsten
    [J]. ONCOLOGY REPORTS, 2018, 40 (05) : 2742 - 2749
  • [26] APOBEC3B expression and its prognostic potential in breast cancer
    Mao, Yan
    Lv, Meng
    Zhang, Yuzi
    Nie, Gang
    Cui, Jian
    Wang, Yongmei
    Wang, Yuanyuan
    Cao, Weihong
    Liu, Xiaoyi
    Wang, Xingang
    Wang, Haibo
    [J]. ONCOLOGY LETTERS, 2020, 19 (04) : 3205 - 3214
  • [27] Structural Characterization of a Minimal Antibody against Human APOBEC3B
    Tang, Heng
    Demir, Ozlem
    Kurniawan, Fredy
    Brown, William L.
    Shi, Ke
    Moeller, Nicholas H.
    Carpenter, Michael A.
    Belica, Christopher
    Orellana, Kayo
    Du, Guocheng
    LeBeau, Aaron M.
    Amaro, Rommie E.
    Harris, Reuben S.
    Aihara, Hideki
    [J]. VIRUSES-BASEL, 2021, 13 (04):
  • [28] Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer
    Carpenter, Michael A.
    Temiz, Nuri A.
    Ibrahim, Mahmoud A.
    Jarvis, Matthew C.
    Brown, Margaret R.
    Argyris, Prokopios P.
    Brown, William L.
    Starrett, Gabriel J.
    Yee, Douglas
    Harris, Reuben S.
    [J]. PLOS GENETICS, 2023, 19 (11):
  • [29] Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain
    Shi, Ke
    Carpenter, Michael A.
    Kurahashi, Kayo
    Harris, Reuben S.
    Aihara, Hideki
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (47) : 28120 - 28130
  • [30] APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication
    Hoopes, James I.
    Cortez, Luis M.
    Mertz, Tony M.
    Malc, Ewa P.
    Mieczkowski, Piotr A.
    Roberts, Steven A.
    [J]. CELL REPORTS, 2016, 14 (06): : 1273 - 1282